News AI could lead to 'golden age' of antibiotics Generative artificial intelligence could hold the key to turning back the rising tide of antimicrobial resistance, say MIT researchers.
R&D Grants for funding pharmaceutical research: Growing without ... Whilst equity investment is likely to be central to the funding strategy of many early-stage biotechs, grant funding can be a very useful alternative.
News Ex-DeepMind scientist launches drug discovery company Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.
R&D Sponsored 12 Questions with Anthony Bradley 12 Questions with Anthony Bradley: novel ways to encode and automate drug design.
Oncology Antibody drug conjugates – The time is now The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
